• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病患者与肺癌患者在生命末期的医疗保健利用差异。

Differences in health care utilization at the end of life among patients with chronic obstructive pulmonary disease and patients with lung cancer.

作者信息

Au David H, Udris Edmunds M, Fihn Stephan D, McDonell Mary B, Curtis J Randall

机构信息

Health Services Research and Development, VA Puget Sound Health Care System, Seattle, Wash, USA.

出版信息

Arch Intern Med. 2006 Feb 13;166(3):326-31. doi: 10.1001/archinte.166.3.326.

DOI:10.1001/archinte.166.3.326
PMID:16476873
Abstract

BACKGROUND

We sought to examine health care resource utilization in the last 6 months of life among patients who died with chronic obstructive pulmonary disease (COPD) compared with those who died with lung cancer and to examine geographic variations in care.

METHODS

We performed a retrospective cohort study of patients diagnosed as having COPD or lung cancer, who were seen in 1 of 7 Veteran Affairs medical centers primary care clinics and who died during the study period. Our outcome of interest was health care resource utilization in the last 6 months of life.

RESULTS

In the last 6 months of life, patients with COPD were more likely to visit their primary care providers but had fewer hospital admissions compared with patients with lung cancer. Patients with COPD had twice the odds of being admitted to an intensive care unit (ICU), 5 times the odds of remaining there 2 weeks or longer, and received fewer opiates and benzodiazepine prescriptions compared with patients with lung cancer. There were geographic variations in the use of ICUs for patients with COPD but not for those with lung cancer. Total health care costs were $4000 higher for patients with COPD because of ICU utilization.

CONCLUSIONS

In the last 6 months of life, patients with COPD were more likely to have had a primary care visit and been admitted to an ICU but less likely to receive palliative medications compared with patients with lung cancer. We found significant geographic variability in ICU utilization but only for patients with COPD.

摘要

背景

我们试图研究慢性阻塞性肺疾病(COPD)死亡患者与肺癌死亡患者在生命最后6个月的医疗资源利用情况,并探讨医疗服务的地理差异。

方法

我们对在7家退伍军人事务医疗中心之一的初级保健诊所就诊且在研究期间死亡的被诊断患有COPD或肺癌的患者进行了一项回顾性队列研究。我们感兴趣的结局是生命最后6个月的医疗资源利用情况。

结果

在生命的最后6个月,与肺癌患者相比,COPD患者更有可能就诊于其初级保健医生,但住院次数较少。与肺癌患者相比,COPD患者入住重症监护病房(ICU)的几率高出两倍,在ICU停留2周或更长时间的几率高出5倍,且接受的阿片类药物和苯二氮䓬类药物处方较少。COPD患者在ICU使用方面存在地理差异,但肺癌患者不存在。由于ICU的使用,COPD患者的总医疗费用高出4000美元。

结论

在生命的最后6个月,与肺癌患者相比,COPD患者更有可能进行初级保健就诊并入住ICU,但接受姑息治疗药物的可能性较小。我们发现ICU使用存在显著的地理差异,但仅存在于COPD患者中。

相似文献

1
Differences in health care utilization at the end of life among patients with chronic obstructive pulmonary disease and patients with lung cancer.慢性阻塞性肺疾病患者与肺癌患者在生命末期的医疗保健利用差异。
Arch Intern Med. 2006 Feb 13;166(3):326-31. doi: 10.1001/archinte.166.3.326.
2
Health care utilization of patients with chronic obstructive pulmonary disease and lung cancer in the last 12 months of life.慢性阻塞性肺疾病和肺癌患者在生命最后12个月的医疗保健利用情况。
Respir Med. 2008 Jun;102(6):885-91. doi: 10.1016/j.rmed.2008.01.007. Epub 2008 Mar 4.
3
Rural/urban differences in health care utilization and place of death for persons with respiratory illness in the last year of life.生命最后一年中呼吸系统疾病患者在医疗保健利用和死亡地点方面的城乡差异。
Rural Remote Health. 2010 Apr-Jun;10(2):1349. Epub 2010 Apr 30.
4
[Costs of the last hospitalization for patients with acute exacerbation of chronic obstructive pulmonary disease and patients with lung cancer].[慢性阻塞性肺疾病急性加重患者和肺癌患者上次住院的费用]
Zhonghua Jie He He Hu Xi Za Zhi. 2009 Apr;32(4):258-61.
5
The impact of palliative care on cancer deaths in Hong Kong: a retrospective study of 494 cancer deaths.姑息治疗对香港癌症死亡的影响:一项对494例癌症死亡病例的回顾性研究。
Palliat Med. 2007 Jul;21(5):425-33. doi: 10.1177/0269216307079825.
6
Outcomes and health-related quality of life following hospitalization for an acute exacerbation of COPD.慢性阻塞性肺疾病急性加重住院后的结局及与健康相关的生活质量
Respirology. 2005 Jun;10(3):334-40. doi: 10.1111/j.1440-1843.2005.00718.x.
7
The cost of treating patients with COPD in Denmark--a population study of COPD patients compared with non-COPD controls.丹麦慢性阻塞性肺疾病患者的治疗成本——一项针对慢性阻塞性肺疾病患者与非慢性阻塞性肺疾病对照人群的研究
Respir Med. 2007 Mar;101(3):539-46. doi: 10.1016/j.rmed.2006.06.020. Epub 2006 Aug 4.
8
Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.与异丙托溴铵相比,使用丙酸氟替卡松500微克/沙美特罗50微克进行初始维持治疗的老年人慢性阻塞性肺疾病住院/急诊就诊风险及治疗费用。
Am J Geriatr Pharmacother. 2008 Aug;6(3):138-46. doi: 10.1016/j.amjopharm.2008.08.005.
9
Comparing noncancer and cancer deaths in Hong Kong: a retrospective review.比较香港的非癌症和癌症死亡:回顾性研究。
J Pain Symptom Manage. 2010 Nov;40(5):704-14. doi: 10.1016/j.jpainsymman.2010.02.023. Epub 2010 Aug 21.
10
Hospital use for COPD patients during the last few years of their life.慢性阻塞性肺疾病(COPD)患者生命最后几年的住院情况。
Respir Med. 2006 Aug;100(8):1436-41. doi: 10.1016/j.rmed.2005.11.003. Epub 2005 Dec 15.

引用本文的文献

1
Cost Disparities with Age in the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC) in Ontario, Canada.加拿大安大略省晚期非小细胞肺癌(NSCLC)治疗中年龄相关的费用差异
Curr Oncol. 2025 Jun 12;32(6):346. doi: 10.3390/curroncol32060346.
2
Associated factors, emergency department visits, and hospitalization days of receiving adjunctive Chinese herbal medicine therapy for patients with non-small cell lung cancer: a nationwide cohort study in Taiwan.非小细胞肺癌患者接受辅助中药治疗的相关因素、急诊就诊情况及住院天数:台湾一项全国性队列研究
Front Pharmacol. 2025 May 20;16:1435541. doi: 10.3389/fphar.2025.1435541. eCollection 2025.
3
Palliative Care in End-Stage Lung Disease.
终末期肺病的姑息治疗
J Hosp Palliat Care. 2025 Mar 1;28(1):25-29. doi: 10.14475/jhpc.2025.28.1.25.
4
General practice utilisation by Australian cancer patients in the last year of life.澳大利亚癌症患者生命最后一年的全科医疗服务利用情况。
Fam Pract. 2025 Feb 7;42(2). doi: 10.1093/fampra/cmae062.
5
Comparison of resuscitation intervention utilization in the emergency department by palliative care eligible patients between cancer and non-cancer.比较癌症和非癌症患者中符合缓和医疗条件的患者在急诊科复苏干预措施的利用情况。
Sci Rep. 2024 Nov 4;14(1):26547. doi: 10.1038/s41598-024-77979-2.
6
The Effect of Opioids and Benzodiazepines on Exacerbation Rate and Overall Survival in Patients with Chronic Obstructive Pulmonary Disease on Long-Term Non-Invasive Ventilation.阿片类药物和苯二氮䓬类药物对长期无创通气的慢性阻塞性肺疾病患者急性加重率和总生存率的影响
J Clin Med. 2024 Sep 22;13(18):5624. doi: 10.3390/jcm13185624.
7
The PROgnostic ModEl for chronic lung disease (PRO-MEL): development and temporal validation.慢性肺病预后模型(PRO-MEL):建立和时间验证。
BMC Pulm Med. 2024 Aug 30;24(1):429. doi: 10.1186/s12890-024-03233-0.
8
Differences in Health Care and Palliative Care Use at the End of Life: A Comparison Study Among Lung Cancer, COPD, and Idiopathic Pulmonary Fibrosis.临终时医疗保健与姑息治疗使用情况的差异:肺癌、慢性阻塞性肺疾病和特发性肺纤维化的比较研究
Chest. 2024 Dec;166(6):1487-1496. doi: 10.1016/j.chest.2024.08.018. Epub 2024 Aug 24.
9
Racial differences in palliative care and hospice among adults with chronic obstructive pulmonary disease.慢性阻塞性肺疾病成人患者姑息治疗和临终关怀中的种族差异。
Respir Med. 2024 Sep;231:107719. doi: 10.1016/j.rmed.2024.107719. Epub 2024 Jun 20.
10
Prognostic models and factors identifying end-of-life in non-cancer chronic diseases: a systematic review.非癌症慢性疾病中识别临终状态的预后模型及因素:一项系统综述
BMJ Support Palliat Care. 2024 Dec 19;14(e3):e2316-e2329. doi: 10.1136/spcare-2023-004656.